BFA
SBBP

BlackRock Fund Advisors’s Strongbridge Biopharma plc. SBBP Stock Holding History

BlackRock Fund Advisors’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$63K Buy
26,448
+266
+1% +$1.08K ﹤0.01% 3708
2016
Q3 		$137K Buy
26,182
+9,978
+62% +$45K ﹤0.01% 3560
2016
Q2 		$64K Buy
+16,204
New +$76.5K ﹤0.01% 3774

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
TAF
Tredje AP-fonden Se-111 91 Stockholm, Sweden $22.1B AUM 41.68% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

BlackRock Fund Advisors's SBBP Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Strongbridge Biopharma plc. (SBBP) stake by 1% in Q4 2016, buying an estimated $1.08K and bringing the position to 26,448 shares worth $63K. The position accounts for ﹤0.01% of the portfolio, ranked #3708.

BlackRock Fund Advisors first reported a position in SBBP in Q2 2016 and has held it in 3 quarters since. The position peaked at $137K in Q3 2016. 18 funds tracked by Wall St. Rank hold SBBP as of Q4 2016.

  • BlackRock Fund Advisors held 26,448 shares of Strongbridge Biopharma plc. worth $63K as of Q4 2016.
  • BlackRock Fund Advisors bought 266 Strongbridge Biopharma plc. shares in Q4 2016, an estimated $1.08K.
  • Strongbridge Biopharma plc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3708 holding.
  • BlackRock Fund Advisors first reported a position in Strongbridge Biopharma plc. in Q2 2016 and has held it in 3 quarters since.
  • BlackRock Fund Advisors's Strongbridge Biopharma plc. position peaked at $137K in Q3 2016.
  • 18 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.